Skip to content

Advancing PRecise Interventions for resistant DEpression: rebalancing brain networks and investigating the trajectories of antidepressant effect with psilocybin and personalized neuromodulation (PRIDE)

Status
Not yet recruiting
Phases
Phase 2
Study type
Interventional
Source
EU CTIS
Registry ID
CTIS2024-519844-34-03
Enrollment
68
Registered
2025-07-08
Start date
Unknown
Completion date
Unknown
Last updated
2025-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Treatment Resistant Depression (TRD)

Brief summary

Non-inferiority (with a 25% margin) in terms of percentage of clinical responders, defined as the reduction in Montgomery-Asberg Depression Rating Scale (MADRS) scores ≥ 50%, after 60 days from the start of the trial.

Detailed description

Hamilton Anxiety Rating Scale (HAM-A) score, Hamilton Depression Rating Scale (HAM-D) score, Brief Psychiatric Rating Scale (BPRS) score, Young Mania Rating Scale (YMRS) score, Snaith-Hamilton Pleasure Scale (SHAPS) scores for anhedonia, Columbia–Suicide Severity Rating Scale and Beck Hopelessness Scale scores for suicide risk, Trail Making Test for attention and executive functions, Clinical Global Impression Severity (CGIS) and Health Status Questionnaire scores for impact of symptoms on health, Functional magnetic resonance imaging (fMRI) analysis for changes in connectivity patterns in TRD-related brain networks, Electroencephalography (EEG) for changes in functional connectivity

Interventions

DRUGPCB2 (inert placebo containing maltodextrin)

Sponsors

Universita' Degli Studi G. D'Annunzio Di Chieti
Lead SponsorOTHER

Eligibility

Sex/Gender
All
Age
18 Years to 64 Years

Design outcomes

Primary

MeasureTime frame
Non-inferiority (with a 25% margin) in terms of percentage of clinical responders, defined as the reduction in Montgomery-Asberg Depression Rating Scale (MADRS) scores ≥ 50%, after 60 days from the start of the trial.

Secondary

MeasureTime frame
Hamilton Anxiety Rating Scale (HAM-A) score, Hamilton Depression Rating Scale (HAM-D) score, Brief Psychiatric Rating Scale (BPRS) score, Young Mania Rating Scale (YMRS) score, Snaith-Hamilton Pleasure Scale (SHAPS) scores for anhedonia, Columbia–Suicide Severity Rating Scale and Beck Hopelessness Scale scores for suicide risk, Trail Making Test for attention and executive functions, Clinical Global Impression Severity (CGIS) and Health Status Questionnaire scores for impact of symptoms on health, Functional magnetic resonance imaging (fMRI) analysis for changes in connectivity patterns in TRD-related brain networks, Electroencephalography (EEG) for changes in functional connectivity

Countries

Italy

Outcome results

None listed

Source: EU CTIS · Data processed: Feb 4, 2026